好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Risk Factors for Injury in a Community-Treated Cohort of Patients with Epilepsy in Tasmania, Australia
Epilepsy/Clinical Neurophysiology (EEG)
(-)
008
Authors/Disclosures
Michael Tan, MD
PRESENTER
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Wendyl J. D'Souza, MD, MBChB Dr. D'Souza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LivaNova, Eisai, UCB, Tilray. Dr. D'Souza has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB Pharma, Eisai Pharmaceutical. Dr. D'Souza has stock in Epiminder. The institution of Dr. D'Souza has received research support from UCB Pharma. The institution of Dr. D'Souza has received research support from Eisai Pharmaceutical.